Thrombopoietin Receptor Agonists in Adult Evans Syndrome: an International Multicenter Experience

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2022 Jun 24

PMID 35749688

Authors

Bruno Fattizzo

Nicola Cecchi

Marta Bortolotti

Giulio Giordano

Andrea Patriarca

Andreas Glenthoj

Silvia Cantoni

Marco Capecchi

Frederick Chen

Maria Eva Mingot-Castellano

Mariasanta Napolitano

Henrik Frederiksen

Tomas Jose Gonzalez-Lopez

Wilma Barcellini

Affiliations

Soon will be listed here.

Citing Articles

Diagnostic and Therapeutic Strategies in Evans Syndrome: A Case Report and Literature Review.

Palvia A, Damera A, Magar S, Nandi A, Goyal M Cureus. 2024; 16(7):e64866.

PMID: 39156320 PMC: 11330688. DOI: 10.7759/cureus.64866.

References

Jager U, Barcellini W, Broome C, Gertz M, Hill A, Hill Q . Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev. 2019; 41:100648. DOI: 10.1016/j.blre.2019.100648. View

Audia S, Bach B, Samson M, Lakomy D, Bour J, Burlet B . Venous thromboembolic events during warm autoimmune hemolytic anemia. PLoS One. 2018; 13(11):e0207218. PMC: 6224177. DOI: 10.1371/journal.pone.0207218. View

Fattizzo B, Zaninoni A, Consonni D, Zanella A, Gianelli U, Cortelezzi A . Is chronic neutropenia always a benign disease? Evidences from a 5-year prospective study. Eur J Intern Med. 2015; 26(8):611-5. DOI: 10.1016/j.ejim.2015.05.019. View

Barcellini W, Zaninoni A, Fattizzo B, Giannotta J, Lunghi M, Ferrari A . Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers. Am J Hematol. 2018; 93(9):E243-E246. DOI: 10.1002/ajh.25212. View

Nozaki Y, Koshiishi M, Sueki Y, Kawashima I, Yamamoto T, Nakajima K . [Successful treatment with rituximab and romiplostim for thrombocytopenia associated with Waldenström's macroglobulinemia initially presenting as Evans syndrome]. Rinsho Ketsueki. 2015; 56(3):317-22. DOI: 10.11406/rinketsu.56.317. View

Blanco B, Garanito M . Pediatric Evans Syndrome: A 20-year experience from a tertiary center in Brazil. Hematol Transfus Cell Ther. 2022; 45(2):196-203. PMC: 10244257. DOI: 10.1016/j.htct.2022.01.011. View

Conti F, Gottardi F, Moratti M, Belotti T, Ferrari S, Selva P . Refractory immune thrombocytopenia successfully treated with bortezomib in a child with 22q11.2 deletion syndrome, complicated by Evans syndrome and hypogammaglobulinemia. Platelets. 2022; 33(5):801-806. DOI: 10.1080/09537104.2021.2002835. View

Shah S, Etzl Jr M . Eltrombopag in long-term management of pediatric thrombocytopenia. Clin Case Rep. 2019; 7(1):196-201. PMC: 6333124. DOI: 10.1002/ccr3.1916. View

Fattizzo B, Michel M, Giannotta J, Hansen D, Arguello M, Sutto E . Evans syndrome in adults: an observational multicenter study. Blood Adv. 2021; 5(24):5468-5478. PMC: 8714709. DOI: 10.1182/bloodadvances.2021005610. View

10.

Palandri F, Rossi E, Bartoletti D, Ferretti A, Ruggeri M, Lucchini E . Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia. Blood. 2021; 138(7):571-583. DOI: 10.1182/blood.2021010735. View

11.

Barcellini W, Giannotta J, Fattizzo B . Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures. Expert Rev Hematol. 2020; 13(6):585-597. DOI: 10.1080/17474086.2020.1754791. View

12.

Neunert C, Terrell D, Arnold D, Buchanan G, Cines D, Cooper N . American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019; 3(23):3829-3866. PMC: 6963252. DOI: 10.1182/bloodadvances.2019000966. View

13.

Evans R, Takahashi K, DUANE R, Payne R, Liu C . Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. AMA Arch Intern Med. 1951; 87(1):48-65. DOI: 10.1001/archinte.1951.03810010058005. View

14.

AlAref S, Salemi A, Minutello R, Bergman G, Wong S . Trans-catheter aortic valve-in-valve implantation in an elderly patient with Evans syndrome. J Cardiol Cases. 2018; 13(5):146-148. PMC: 6280733. DOI: 10.1016/j.jccase.2016.01.003. View

15.

Ruiz-Arguelles G, Ruiz-Delgado G, Velazquez-Sanchez-de-Cima S, Zamora-Ortiz G . Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab. Hematology. 2013; 18(3):175-7. DOI: 10.1179/1607845412Y.0000000060. View

16.

Gonzalez-Nieto J, Martin-Suarez I, Quattrino S, Ortiz-Lopez E, Munoz-Beamud F, Colchero-Fernandez J . The efficacy of romiplostim in the treatment of severe thrombocytopenia associated to Evans syndrome refractory to rituximab. Lupus. 2011; 20(12):1321-3. DOI: 10.1177/0961203311404913. View

17.

Rodeghiero F . Is ITP a thrombophilic disorder?. Am J Hematol. 2015; 91(1):39-45. DOI: 10.1002/ajh.24234. View

18.

Santosa D, Sofro M, Farida , Nindita N, Pangarsa E, Setiawan B . A full-term pregnant woman with secondary Evans syndrome caused by severe coronavirus disease 2019: a case report. J Med Case Rep. 2021; 15(1):606. PMC: 8667974. DOI: 10.1186/s13256-021-03205-6. View

19.

Alvarez-Roman M, Fernandez-Bello I, Jimenez-Yuste V, Martin-Salces M, Arias-Salgado E, Rivas Pollmar M . Procoagulant profile in patients with immune thrombocytopenia. Br J Haematol. 2016; 175(5):925-934. DOI: 10.1111/bjh.14412. View

20.

Michel M, Chanet V, Dechartres A, Morin A, Piette J, Cirasino L . The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases. Blood. 2009; 114(15):3167-72. DOI: 10.1182/blood-2009-04-215368. View